6850.TWO
Price:
$41.25
Market Cap:
$1.36B
BiOptic Inc., a biotechnology instrumentation company, develops scientific products for research and clinical applications. It offers instruments, such as bio-fragment analyzers and PCR thermocyclers; consumables, including DNA, RNA, and protein cartridges, as well as quantification kits; premix and polymerase PCR reagents; and veterinary, human, and food related testing kits. BiOptic Inc.was founded in 1993 and is headquartered in New Taipei City, Taiwan.
Industry
Biotechnology
IPO Date
2021-11-10
Stock Exchange
TWO
Ticker
6850.TWO
According to BiOptic Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 64.45. This represents a change of 69.81% compared to the average of 37.96 of the last 4 quarters.
The mean historical PE Ratio of BiOptic Inc. over the last ten years is 60.90. The current 64.45 PE Ratio has changed 10.48% with respect to the historical average. Over the past ten years (40 quarters), 6850.TWO's PE Ratio was at its highest in in the June 2025 quarter at 63.65. The PE Ratio was at its lowest in in the December 2022 quarter at 6.49.
Average
60.90
Median
29.92
Minimum
-47.78
Maximum
322.82
Discovering the peaks and valleys of BiOptic Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 120.81%
Maximum Annual PE Ratio = 322.82
Minimum Annual Increase = -775.62%
Minimum Annual PE Ratio = -47.78
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 51.77 | 47.43% |
| 2023 | 35.11 | 120.81% |
| 2022 | 15.90 | -14.32% |
| 2021 | 18.56 | -37.97% |
| 2020 | 29.92 | -90.73% |
| 2019 | 322.82 | -775.62% |
The current PE Ratio of BiOptic Inc. (6850.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
34.26
5-year avg
30.25
10-year avg
60.90
BiOptic Inc.’s PE Ratio is greater than GeneReach Biotechnology Corp. (-7.89), greater than Great Novel Therapeutics Biotech & Medicals (-16.86), greater than Enimmune corporation (-6.86), greater than NaviFUS Corp. (-12.21), greater than Taiwan Advance Bio-Pharmaceutical Inc. (44.82), less than GenMont Biotech Incorporation (103.62), greater than MegaPro Biomedical Co., Ltd (-5.63), greater than Abnova (Taiwan) Corporation (-212.57), greater than NeoCore Technology Co., Ltd. (-83.93), greater than LabTurbo Biotech Corporation (-7.06),
| Company | PE Ratio | Market cap |
|---|---|---|
| -7.89 | $1.10B | |
| -16.86 | $1.48B | |
| -6.86 | $1.44B | |
| -12.21 | $1.45B | |
| 44.82 | $1.05B | |
| 103.62 | $1.59B | |
| -5.63 | $1.02B | |
| -212.57 | $1.38B | |
| -83.93 | $1.52B | |
| -7.06 | $1.12B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BiOptic Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BiOptic Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BiOptic Inc.'s PE Ratio?
How is the PE Ratio calculated for BiOptic Inc. (6850.TWO)?
What is the highest PE Ratio for BiOptic Inc. (6850.TWO)?
What is the 3-year average PE Ratio for BiOptic Inc. (6850.TWO)?
What is the 5-year average PE Ratio for BiOptic Inc. (6850.TWO)?
How does the current PE Ratio for BiOptic Inc. (6850.TWO) compare to its historical average?